KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bristol Myers Squibb (BMY) Tax Provisions (2016 - 2025)

Bristol Myers Squibb (BMY) has disclosed Tax Provisions for 17 consecutive years, with $384.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Tax Provisions rose 287.88% to $384.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.3 billion, a 310.11% increase, with the full-year FY2025 number at $2.3 billion, up 310.11% from a year prior.
  • Tax Provisions was $384.0 million for Q4 2025 at Bristol Myers Squibb, down from $919.0 million in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $919.0 million in Q3 2025 to a low of -$514.0 million in Q4 2021.
  • A 5-year average of $283.9 million and a median of $432.0 million in 2022 define the central range for Tax Provisions.
  • Peak YoY movement for Tax Provisions: tumbled 141.21% in 2023, then surged 287.88% in 2025.
  • Bristol Myers Squibb's Tax Provisions stood at -$514.0 million in 2021, then soared by 67.7% to -$166.0 million in 2022, then soared by 46.99% to -$88.0 million in 2023, then soared by 212.5% to $99.0 million in 2024, then soared by 287.88% to $384.0 million in 2025.
  • Per Business Quant, the three most recent readings for BMY's Tax Provisions are $384.0 million (Q4 2025), $919.0 million (Q3 2025), and $460.0 million (Q2 2025).